Evidence map›Paper›PMID 37938378›Full record

ReviewGraefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie2024

Additional measures of macular function beyond visual acuity.

Hernán Andrés Ríos, Monica Lövestam-Adrian, Sotiris Plainis, Miltiadis Tsilimbaris, Antonia M Joussen, David Keegan, Martin Charles, José Cunha-Vaz, Edoardo Midena

Open access · hybridAbstract readReview
In one paragraph

Review in Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Predicting Letter Acuity Using Vernier-Induced OKN and Consumer-Grade Cameras.Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists) · 2026
    Article
  3. Article
  4. Article
  5. Visual Function Assessment in Geographic Atrophy: A Review.Clinical & experimental ophthalmology · 2026
    Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 7 institutions in 7 countries.

Hernán Andrés RíosRetina y Vítreo, Fundación Oftalmológica Nacional, Universidad del Rosario, Bogotá, Colombia.
Monica Lövestam-AdrianDepartment of Ophthalmology, Lund University Hospital, Lund, Sweden.
Sotiris PlainisLaboratory of Optics and Vision, University of Crete Medical School, Heraklion, Crete, Greece.
Miltiadis TsilimbarisLaboratory of Optics and Vision, University of Crete Medical School, Heraklion, Crete, Greece.
Antonia M JoussenCharité - University Medicine Berlin, Berlin, Germany.
David KeeganDepartment of Ophthalmology, Mater Misericordiae University Hospital, Dublin, Ireland.
Martin CharlesCharles, Centro Oftalmológico, Buenos Aires, Argentina.
José Cunha-VazAIBILI - Association for Innovation and Biomedical Research on Light and Image, Coimbra, Portugal.
Edoardo MidenaDepartment of Ophthalmology, University of Padova, Padua, Italy. edoardo.midena@unipd.it.ORCID http://orcid.org/0000-0003-3132-6233
University of Crete · GRAssociation for Innovation and Biomedical Research on Light and Image · PTCharité - Universitätsmedizin Berlin · DELund University · SEMater Misericordiae University Hospital · IEUniversidad del Rosario · COUniversity of Padua · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeVisual function is a complex process in which external visual stimuli are interpreted. Patients with retinal diseases and prolonged follow-up times may experience changes in their visual function that are not detected by the standard visual acuity measure, as they are a result of other alterations in visual function. With the advancement of different methods to evaluate visual function, additional measurements have become available, and further standardization suggests that some methods may be promising for use in clinical trials or routine clinical practice. The objectives of this article are to review these additional measurements and to provide guidance on their application.

methodsThe Vision Academy's membership of international retinal disease experts reviewed the literature and developed consensus recommendations for the application of additional measures of visual function in routine clinical practice or clinical trials.

resultsMeasures such as low-luminance visual acuity, contrast sensitivity, retinal fixation and microperimetry, and reading performance are measures which can complement visual acuity measurements to provide an assessment of overall visual function, including impact on patients' quality of life. Measures such as dark adaptation, color vision testing, binocular vision testing, visual recognition testing, and shape discrimination require further optimization and validation before they can be implemented in everyday clinical practice.

conclusionAdditional measurements of visual function may help identify patients who could benefit from earlier diagnosis, detection of disease progression, and therapeutic intervention. New and additional functional clinical trial endpoints are required to fully understand the early stages of macular disease, its progression, and the response to treatment.

Indexed as

Contrast SensitivityVisual AcuityDark AdaptationHumansMacula LuteaQuality of LifeRetinal DiseasesVision TestsVisual Field TestsElectrophysiological testPsychophysical testVisionVisual acuity

Identifiers

PMID37938378
PMCPMC11106142
OpenAlexW4388484275

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.